Acadian Asset Management
KYNB

Acadian Asset Management’s Kyntra Bio KYNB Stock Holding History

Acadian Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$795K Hold
105,585
– – ﹤0.01% 1328
2026
Q1 		$714K Hold
105,585
– – ﹤0.01% 1263
2025
Q4 		$925K Sell
105,585
-4,696
-4% -$45.9K ﹤0.01% 1132
2025
Q3 		$1.35M Sell
110,281
-28,840
-21% -$271K ﹤0.01% 981
2025
Q2 		$735K Sell
139,121
-17,093
-11% -$125K ﹤0.01% 1055
2025
Q1 		$1.21M Hold
156,214
– – ﹤0.01% 883
2024
Q4 		$2.06M Hold
156,214
– – 0.01% 756
2024
Q3 		$1.56M Buy
156,214
+21,625
+16% +$326K ﹤0.01% 814
2024
Q2 		$3M Buy
134,589
+34,434
+34% +$1.06M 0.01% 649
2024
Q1 		$5.88M Buy
100,155
+1,398
+1% +$60.2K 0.02% 433
2023
Q4 		$2.19M Buy
98,757
+34,153
+53% +$515K 0.01% 650
2023
Q3 		$1.39M Buy
+64,604
New +$2.54M 0.01% 781
2022
Q1 		– Sell
-56
Closed -$19K – 1687
2021
Q4 		$19K Buy
+56
New +$17.4K ﹤0.01% 1614
2021
Q3 		– Sell
-844
Closed -$562K – 1803
2021
Q2 		$562K Buy
844
+180
+27% +$104K ﹤0.01% 1111
2021
Q1 		$576K Buy
664
+640
+2,667% +$681K ﹤0.01% 1141
2020
Q4 		$22K Buy
+24
New +$25.2K ﹤0.01% 2134
2020
Q2 		– Sell
-27
Closed -$23K – 2261
2020
Q1 		$23K Sell
27
-115
-81% -$114K ﹤0.01% 1634
2019
Q4 		$152K Buy
+142
New +$145K ﹤0.01% 1353
2017
Q3 		– Sell
-3,180
Closed -$2.57M – 1436
2017
Q2 		$2.57M Sell
3,180
-2,760
-46% -$1.92M 0.01% 521
2017
Q1 		$3.66M Buy
5,940
+5,558
+1,455% +$3.38M 0.02% 478
2016
Q4 		$204K Buy
+382
New +$191K ﹤0.01% 998
2016
Q3 		– Sell
-259
Closed -$106K – 1465
2016
Q2 		$106K Buy
+259
New +$119K ﹤0.01% 1021
2016
Q1 		– Sell
-139
Closed -$106K – 1402
2015
Q4 		$106K Buy
+139
New +$92.2K ﹤0.01% 1062

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management's KYNB Position: Q2 2026 in Review

Acadian Asset Management held its Kyntra Bio (KYNB) position steady in Q2 2026 at 105,585 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

Acadian Asset Management first reported a position in KYNB in Q4 2015 and has held it in 23 quarters since. The position peaked at $5.88M in Q1 2024. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • Acadian Asset Management held 105,585 shares of Kyntra Bio worth $795K as of Q2 2026.
  • Acadian Asset Management left its Kyntra Bio share count unchanged in Q2 2026.
  • Kyntra Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1328 holding.
  • Acadian Asset Management first reported a position in Kyntra Bio in Q4 2015 and has held it in 23 quarters since.
  • Acadian Asset Management's Kyntra Bio position peaked at $5.88M in Q1 2024.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.